FdaApplication
ANDA 206736
Identifiers
- fda_app_no: ANDA206736
Properties
| Property | Value |
|---|---|
| applicant_name | WATSON PHARMACEUTICALS INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC |
| application_type | ANDA |
| approval_date | 2016-01-19 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RIFAMPIN | RIFAMPIN | 600MG/VIAL | INJECTABLE;INJECTION |
1 product